Eckert & Ziegler Strahlen- und Medizintechnik AG

Board/Management Information • Feb 17, 2004

News Details

Corporate | 17 February 2004 12:06

Change in the Supervisory Board of Eckert & Ziegler

Corporate-news announcement sent by DGAP. The sender is solely responsible for the contents of this announcement. ——————————————————————————– Berlin, February 17, 2004. The long-standing member of the Supervisory Board of Eckert & Ziegler AG (ISIN DE 0005659700), Prof. Dr. Detlev Ganten, has resigned his seat on the Supervisory Board of the medical technology company in Buch, due to his appointment as Chairman of the Executive Board of the Charité University Medical Department, Berlin. He said that he would have to “concentrate completely on his new duties”; nonetheless, he would maintain a friendly relationship with the enterprise. Ganten had been appointed to the control committee of Eckert & Ziegler AG in 1998 and had accompanied the enterprise on its rise to a stock exchange listing and on its growth to an international isotope specialist with a sales volume of 30 million EUR and some 220 employees. As the statute and Stockholders Meeting stipulation specify, the Berlin businessman Hans-Jörg Hinke will take over Ganten’s seat on the Supervisory Board until a new member is chosen. Your contact for additional information: Eckert & Ziegler Strahlen- und Medizintechnik AG Karolin Riehle, Investor Relations Tel.: +49 (0) 30 / 94 10 84-138 www.ezag.de end of message, (c)DGAP 17.02.2004 ——————————————————————————– WKN: 565970; ISIN: DE0005659700; Index: Listed: Geregelter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin- Bremen, Düsseldorf, Hamburg, Hannover und Stuttgart 171206 Feb 04